Neonati pretermine

La Neonatologia ai tempi di JFK...

Corsello G.

2021/10 — pag. 627 — DOI

La carenza di ferro nel neonato pretermine

V. Guastalla, M.C. Pellegrin, F. Rovere, R. Davanzo

2015/5 — pag. 298-305

Iron deficiency is the most common micronutrient deficiency worldwide. Preterm infants are a special risk group, because of lower total body iron at birth, rapid catch-up growth and uncompensated phlebotomy losses. Recent scientific literature sugg...

Perforazione esofagea in neonato pretermine

I. Mauro, E. Villa, L. Leva, M. Barbarini

2015/4

The paper describes a case of a baby of 26 weeks of gestation. At birth she was intubated in delivery room for respiratory insufficiency, but she needed repeated attempts at endotracheal intubation. She was extubated on the 3rd day of life and non in...

Il latte materno spremuto è efficace come analgesia nel pretermine?

G. Cont, C. De Pieri, G. Baldassi, P. Brovedani, M. Montico, R. Davanzo

2014/4

L’ossigenoterapia ad alti flussi in neonatologia

G. Maffei, R. Magaldi

2013/1 — pag. 39-41

The Authors reviewed the literature on the effects of heated humidified high flow nasal cannula (HHHFNC) treatment in preterm infants. The HHHFNC delivers a continuous distending pressure (CDP) in smaller infants proportional to the flow that is ex...

… E se il dotto arterioso pervio persiste nonostante la terapia con ibuprofene?

A. Secinaro, E. Antonielli d’Oulx, P. Manzoni, D. Farina, M.L. Leonessa, G. Gomirato

2006/7 — pag. 463-464

Patent ductus arteriosus (PDA) with significant left-to-right shunt is a major cause of increased morbidity and mortality in preterm infants. Early closure of ductus arteriosus may be pharmacologically achieved using cyclooxygenase inhibitors, or via...

Effetto dell'ossido nitrico inalato nei nati pretermine con grave insufficienza respiratoria

G. Bartolozzi

2005/9

Infusione di morfina nei neonati pretermine ventilati.

T. Gerarduzzi

2003/9

L'uso delle IgG per bocca non previene l'enterocolite necrotizzante

G. Bartolozzi

2001/9

Palivizumab: un anticorpo monoclonale umanizzato contro il virus respiratorio sinciziale

L. De Seta, G. Orso

1999/8 — pag. 491-494

Respiratory Syncytial Virus (RSV) is the main cause of respiratory infections in the first years of life. Preterm infants and those affected by broncopulmonary dysplasia (BPD) represent the categories at highest risk of severe RSV infections. Paliv...